WUXI BIOLOGICS (CAYMAN) INC. earnings per share and revenue

1FW2 earnings per share for the last semiannual are 0.04 EUR whereas the estimation was 0.03 EUR which accounts for 22.00% surprise. Company revenue for the same period amounts to 1.09 B EUR despite the estimated figure of 1.07 B EUR. Estimated earnings per share for the next semiannual are 0.05 EUR, and revenue is expected to reach 1.01 B EUR. Also watch annual changes over time to get a bigger picture of 1FW2 earnings per share and revenue dynamics.